Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02869451 · ClinicalTrials.gov registry record · NA
Mobile Contingency Management for Marijuana and Tobacco Cessation
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT02869451 is a NA study that has completed, run by Duke University. The registered enrollment target is 7 participants.
The verdict
NCT02869451, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
The purpose of this pilot project is to pilot-test a combined cannabis and smoking cessation treatment. The intervention combines mobile technology with behavioral strategies, counseling, and medications.
Interventions
- DRUG bupropion
- DRUG Nicotine polacrilex
- DRUG transdermal nicotine patch
- DRUG nicotine lozenge
- BEHAVIORAL counseling for marijuana and smoking cessation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2016-08 |
| Est. Completion | 2017-05-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02869451
The ClinicalTrials.gov registry entry for NCT02869451 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which bupropion is the first listed.
NCT02869451 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02869451 about?
NCT02869451 is a clinical study titled "Mobile Contingency Management for Marijuana and Tobacco Cessation". The purpose of this pilot project is to pilot-test a combined cannabis and smoking cessation treatment. The intervention combines mobile technology with behavioral strategies, counseling, and medications.
What is the current status of trial NCT02869451?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2016-08. Estimated completion is 2017-05-17.
What interventions are being tested in trial NCT02869451?
The interventions under investigation include: bupropion (DRUG), Nicotine polacrilex (DRUG), transdermal nicotine patch (DRUG), nicotine lozenge (DRUG), counseling for marijuana and smoking cessation (BEHAVIORAL).
Who is sponsoring clinical trial NCT02869451?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.